Mode
Text Size
Log in / Sign up

Meta-analysis of minimally invasive vs open hepatectomy in patients with obesity and liver tumorsLess Pain, Less Blood: Surgery for Obese Liver Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that minimally invasive hepatectomy is associated with shorter operative time and reduced blood loss compared to open hepatectomy in this meta-analysis.

This systematic review and meta-analysis assessed the comparative effectiveness of minimally invasive hepatectomy (MIH) versus open hepatectomy (OH) for patients with obesity and liver tumors. The analysis included 1,713 patients across the included studies. The authors synthesized data on secondary outcomes including operative time, blood loss, blood transfusion rate, tumor size, overall and major postoperative complications, biliary leakage, liver failure, mortality, and length of hospital stay. Primary outcomes were not reported in the source document.

Regarding operative metrics, MIH was associated with a shorter operative time, with a weighted mean difference (WMD) of -54.50 minutes (95% CI = -96.28 to -12.72, P = 0.01). Additionally, MIH was associated with reduced blood loss, showing a WMD of -416.80 mL (95% CI = -579.84 to -253.76, P = 0.01). The source did not provide absolute numbers for these specific outcomes.

Safety and tolerability data were not reported in the source. The authors did not report discontinuations or serious adverse events. Limitations acknowledged by the authors were not reported. The study phase was not reported. The setting of the included studies was not reported. Follow-up duration was not reported. Causality notes were not provided. The certainty of the evidence was not explicitly graded in the source. Practice relevance was not explicitly stated by the authors. The study type is a meta-analysis, not a primary trial.

Imagine having to choose between a large incision and a tiny keyhole for a serious liver problem. For many people with obesity, this choice used to be very difficult. Doctors often hesitated to perform minimally invasive surgery on these patients. They worried the extra weight would make the procedure too risky or impossible.

Obesity is becoming more common around the world. When a person has a heavy liver tumor, they need surgery to remove it. But standard open surgery involves a huge cut in the belly. This leads to a lot of pain and a long time to heal. Many patients struggle to move or eat normally for weeks after this big operation.

Doctors have long debated if small cuts work for heavier patients. Some thought the extra fat made it too hard to see inside the body. Others feared that the surgery would take too long or cause too much bleeding. This uncertainty left many patients without the best option available to them.

The surprising shift

But here's the twist. A new look at the data changes everything. Researchers compared the old way (open surgery) with the new way (minimally invasive surgery) specifically for patients with obesity. They found that the small-cut approach actually works better in many ways. It does not make the surgery harder. In fact, it makes things easier for the patient.

What scientists didn't expect

Think of the liver like a busy city. Open surgery is like tearing down a whole neighborhood to fix a pipe. Minimally invasive surgery is like using a robot arm to fix the pipe through a small hole in the wall. For a long time, people thought the "fat" in the city would block the robot arm. The new study shows the robot arm can still work well, even with extra weight.

Who was studied

To get clear answers, scientists looked at eleven different studies. These studies included a total of 1,713 patients. All of these people had obesity and liver tumors. The team carefully compared how long the surgery took, how much blood was lost, and how many complications happened. They checked everything from the time in the hospital to the risk of serious infection.

The results were clear and encouraging. Patients who had the minimally invasive procedure spent less time under the knife. On average, the surgery took about 55 minutes less than the open version. This shorter time means the body has less stress during the operation.

This doesn't mean this treatment is available yet.

Another big win was blood loss. The minimally invasive group lost significantly less blood than the open surgery group. Less blood loss means fewer patients needed a blood transfusion. It also means the body can focus on healing instead of replacing lost fluids. The recovery time was faster, and patients left the hospital sooner.

If you or a loved one has a liver tumor and obesity, this news is hopeful. It suggests that you might be able to avoid a massive cut in your belly. You could wake up from surgery with less pain and start moving again sooner. However, this does not mean every patient is a perfect candidate. Your doctor will still need to check your specific health situation.

The catch

Even with good news, we must be honest about the limits. This study combined data from many places. While the numbers look great, every patient is different. Some doctors might still prefer the open method for very complex cases. It is important to talk to your surgeon about what is right for your body.

What happens next

This research gives doctors a new tool to offer to their patients. It opens the door for more people to get the benefits of small-cut surgery. In the future, we may see even better tools that make these surgeries even safer. But for now, the message is simple: do not rule out minimally invasive surgery just because of weight. Ask your doctor if it is an option for you.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BackgroundMinimally invasive hepatectomy (MIH) has been considered a safe and feasible treatment approach for liver resection in recent years. However, the application of MIH in patients with obesity still remains controversial, and the outcomes of MIH vs. open hepatectomy (OH) have not been fully evaluated. Our objective is to compare the surgical outcomes of MIH with OH in patients with obesity and liver tumors.MethodsAll studies comparing MIH with OH in patients with obesity and liver tumors were identified through a systematic search of the PubMed, Embase, Web of Science, Cochrane Library, WanFang, and CNKI databases. Statistical analysis was conducted using Review Manager version 5.4 software. The final search was conducted on 20 May 2025. The surgical outcomes included operative time, blood loss, blood transfusion rate, tumor size, overall and major postoperative complications, biliary leakage, liver failure, mortality, and length of hospital stay.ResultsEleven studies with a total of 1,713 patients were included in this meta-analysis. Compared with OH, MIH was associated with a shorter operative time [weighted mean difference (WMD) = −54.50, 95% confidence interval (CI) = −96.28 to −12.72, P = 0.01], reduced blood loss (WMD = −416.80, 95% CI = −579.84 to −253.76, P 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.